After undergoing the stress and physical challenges of a bone marrow or stem cell transplant, it can be disheartening to hear that you have been diagnosed with graft-versus-host disease (GvHD). The complication, in which transplanted cells from a donor triggers an autoimmune-like assault on healthy tissues and organs, is more common than one might think.…
Graft-versus-host disease (GvHD) is a complication of a stem cell or bone marrow transplant in which transplanted cells from a donor triggers an abnormal immune response in the recipient, causing the immune system to attack its own tissues and organs. As a condition characterized by an inappropriate immune response, GvHD is primarily treated with medications called immunosuppressants. Depending on which…
Graft-versus-host disease (GvHD) is a complication of a bone marrow or stem cell transplant in which cells from a donor attack the tissues of the recipient. GvHD can be classified as being either acute (occurring within 100 days of the transplant) or chronic (occurring 100 days or more after the transplant). Wolfe D, Lawitschka A. Chapter…
Graft-versus-host disease (GvHD) is a complication of a stem cell or bone marrow transplant caused by a genetic mismatch between the cells of the donor and the recipient. Although there is no way to predict who will develop GvHD, certain risk factors can increase the likelihood of this common complication. While most risk factors are…
Mohs surgery is a form of skin cancer treatment. It involves surgically removing thin layers of skin, examining each layer for signs of cancer, and then continuing the process until no cancer cells are detected in the layers. The primary goal of Mohs surgery is to remove all skin affected…
